![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Bausch + Lomb Achieves FDA Clearance for Crystalsert Injector
Bausch + Lomb Achieves FDA Clearance for Crystalsert Injector
January 4, 2018
The FDA issued 510(k) marketing clearance for the Bausch + Lomb Cystalsert 2.6 injector.
The first-of-its-kind FDA-cleared injector can be used across the company’s suite of intraocular lenses.
The CI-26 allows for easy wound entry and helps prevent tissue snagging via an incision as small as 2.6 mm, the company said.
Upcoming Events
-
21Oct